J. Beuth
Impact in
- Biotechnology top 2%
- Transgenic Plants and Applications
- Immunology top 5%
- Toxin Mechanisms and Immunotoxins
Papers in
-
- Glycosylation and Glycoproteins Research 11
- Immunology 38
- Toxin Mechanisms and Immunotoxins 25
- Immune Response and Inflammation 7
- Co-authors
- G. Pulverer (52 shared papers)H.L. Ko (38 shared papers)G. Uhlenbruck (16 shared papers)Jörg Michael Schierholz (9 shared papers)Berthold Schneider (5 shared papers)K. Oette (6 shared papers)Hans‐Joachim Gabius (4 shared papers)W. Roszkowski (11 shared papers)
- Journals
- Journal of Cancer Research and Clinical Oncology (3 papers)Medical Microbiology and Immunology (3 papers)Infection (2 papers)Journal of Medical Microbiology (1 paper)ORL (1 paper)
- Partner nations
- GermanyPolandUnited Kingdom
In The Last Decade
J. Beuth
108 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 115
- Biotechnology 293
- Immunology 669
- Complementary and alternative medicine 201
- Microbiology 104
- Complementary and Manual Therapy 22
Countries citing papers authored by J. Beuth
This map shows the geographic impact of J. Beuth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Beuth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Beuth more than expected).
Fields of papers citing papers by J. Beuth
This network shows the impact of papers produced by J. Beuth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Beuth. The network helps show where J. Beuth may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Beuth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. | 2004 | 126 |
| 2 | Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany. | 2012 | 114 |
| 3 | 1992 | 82 | |
| 4 | Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe. | 2000 | 78 |
| 5 | 1997 | 64 | |
| 6 | 1987 | 60 | |
| 7 | 2001 | 57 | |
| 8 | 1995 | 57 | |
| 9 | 2004 | 55 | |
| 10 | Influence of treatment with the immunomodulatory effective dose of the beta-galactoside-specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental model systems. | 1991 | 53 |
| 11 | Safety and efficacy of local administration of contractubex to hypertrophic scars in comparison to corticosteroid treatment. Results of a multicenter, comparative epidemiological cohort study in Germany. | 2006 | 52 |
| 12 | Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study. | 2004 | 49 |
| 13 | 2008 | 41 | |
| 14 | 2000 | 40 | |
| 15 | 1990 | 33 | |
| 16 | Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled multicenter comparative epidemiological cohort study. | 2008 | 31 |
| 17 | 2003 | 30 | |
| 18 | [Comparative studies on the immunoactive action of galactoside-specific mistletoe lectin. Pure substance compared to the standardized extract]. | 1993 | 29 |
| 19 | 1986 | 26 | |
| 20 | 1987 | 26 |
About J. Beuth
J. Beuth is a scholar working on Molecular Biology, Immunology, Biotechnology, Microbiology and Infectious Diseases, having authored 116 papers that have together received 1.9k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (25 papers), Transgenic Plants and Applications (17 papers), Cancer Research and Treatments (13 papers), Antimicrobial Peptides and Activities (13 papers), Glycosylation and Glycoproteins Research (11 papers), Complementary and Alternative Medicine Studies (10 papers), Plant Parasitism and Resistance (8 papers) and Immune Response and Inflammation (7 papers). The work is most often cited by research in Biotechnology (293 citations), Immunology (669 citations), Complementary and alternative medicine (201 citations), Microbiology (104 citations) and Complementary and Manual Therapy (22 citations). J. Beuth has collaborated with scholars based in Germany, Poland and United Kingdom. Frequent co-authors include G. Pulverer, H.L. Ko, G. Uhlenbruck, Jörg Michael Schierholz, Berthold Schneider, K. Oette, Hans‐Joachim Gabius, W. Roszkowski, B Schneider and Jan-Matthias Braun. Their work appears in journals such as Journal of Cancer Research and Clinical Oncology, Medical Microbiology and Immunology, Infection, Journal of Medical Microbiology and ORL.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.